Cargando…
Translatability scoring in drug development: eight case studies
Translational medicine describes the transfer of basic in vitro and in vivo data into human applications. In the light of low rates of market approvals for new medical entities, better strategies to predict the risk of drug development should be used to increase output and reduce costs. Recently, a...
Autores principales: | Wendler, Alexandra, Wehling, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330010/ https://www.ncbi.nlm.nih.gov/pubmed/22397594 http://dx.doi.org/10.1186/1479-5876-10-39 |
Ejemplares similares
-
Translatability scoring in prospective and retrospective COVID drug development cases
por: Wendler, Alexandra, et al.
Publicado: (2023) -
Translatability score revisited: differentiation for distinct disease areas
por: Wendler, Alexandra, et al.
Publicado: (2017) -
Translational medicine: science or wishful thinking?
por: Wehling, Martin
Publicado: (2008) -
Eight papers translated from the russian
por: Belonogov, V A, et al.
Publicado: (1989) -
Eight papers translated from the Russian
por: Dalalyan, S G, et al.
Publicado: (1989)